Healthcare reform bill clears House

The House of Representatives' version of the healthcare reform bill, dubbed the America's Affordable Health Choices Act of 2009, includes the provisions of the Physician Payment Sunshine Act, which would mandate sweeping transparency measures for pharmas. 


The legislation would require companies to report all grants to CME providers, though reporting of attendees and expenses would not be required. An earlier version of the legislation drew the support of Lilly and other drugmakers. The House version includes language establishing federal pre-emption for collecting information covered by the bill, meant to increase public disclosure of payments.

You must be a registered member of MMM to post a comment.
close

Next Article in Features


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.